Literature DB >> 32288233

François Freymuth1, Geneviève Eugène1, Jacques Brouard1, Astrid Vabret1, Joëlle Petitjean1, Françoise Bonnin1.   

Abstract

Les bronchiolites à VRS sont fréquentes, épidémiques et nécessitent parfois l'hospitalisation des nourrissons, voire une réanimation.Le déterminisme des lésions pulmonaires est complexe, lié au virus et à la réaction immunitaire. Le traitement est symptomatique, et l'utilisation de la ribavirine est limitée aux formes sévères. Le diagnostic virologique doit être rapide, et la recherche immunologique directe des protéines virales est la technique la plus utilisée.
Copyright © 1995 Published by Elsevier Masson SAS.

Entities:  

Year:  2000        PMID： 32288233      PMCID： PMC7146807          DOI： 10.1016/0924-4204(96)83603-1

Source DB:  PubMed          Journal:  Ann Inst Pasteur Actual        ISSN： 0924-4204


  52 in total

1.  Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

Authors:  L J Anderson; J C Hierholzer; C Tsou; R M Hendry; B F Fernie; Y Stone; K McIntosh
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

2.  Rapid diagnosis of respiratory syncytial virus infections in children.

Authors:  F Freymuth
Journal:  Lancet       Date:  1980-09-06       Impact factor: 79.321

Review 3.  Detection, pathogenesis, and therapy of respiratory syncytial virus infections.

Authors:  R C Welliver
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

Authors:  R C Welliver; D T Wong; M Sun; E Middleton; R S Vaughan; P L Ogra
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

5.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

6.  Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.

Authors:  P F Wright; R B Belshe; H W Kim; L P Van Voris; R M Chanock
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.

Authors:  V G Hemming; W Rodriguez; H W Kim; C D Brandt; R H Parrott; B Burch; G A Prince; P A Baron; R J Fink; G Reaman
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

8.  Pathological changes in virus infections of the lower respiratory tract in children.

Authors:  W Aherne; T Bird; S D Court; P S Gardner; J McQuillin
Journal:  J Clin Pathol       Date:  1970-02       Impact factor: 3.411

9.  Respiratory syncytial virus infection in immunocompromised adults.

Authors:  J A Englund; C J Sullivan; M C Jordan; L P Dehner; G M Vercellotti; H H Balfour
Journal:  Ann Intern Med       Date:  1988-08-01       Impact factor: 25.391

10.  A single-season epidemic with respiratory syncytial virus subgroup B2 during 10 epidemic years, 1978 to 1988.

Authors:  M A Mufson; B Akerlind-Stopner; C Orvell; R B Belshe; E Norrby
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.